Фармакология
820 статей · 39 журналов
Журналы подкатегории (39)
- Biomedicine & Pharmacotherapy · Elsevier (90)
- Drug and Alcohol Dependence · Elsevier (88)
- Fitoterapia · Elsevier (85)
- Progress in Neuro-Psychopharmacology & Biological Psychiatry · Elsevier (80)
- Neuropsychopharmacology · Elsevier (68)
- Neurotherapeutics · Elsevier (58)
- Steroids · Elsevier (47)
- Drug Resistance Updates · Elsevier (45)
- The Journal of Pharmacology and Experimental Therapeutics · Elsevier (43)
- Intelligent Pharmacy · Elsevier (34)
- Drug Metabolism and Disposition · Elsevier (32)
- Current Radiopharmaceuticals · Elsevier (31)
- European Neuropsychopharmacology · Elsevier (27)
- Pharmacological Reviews · Elsevier (27)
- Prostaglandins & Other Lipid Mediators · Elsevier (16)
- Molecular Pharmacology · Elsevier (14)
- Medicine in Drug Discovery · Elsevier (11)
- Acta Pharmacologica Sinica · Springer Nature (8)
- Nature Reviews Drug Discovery · Springer Nature (8)
- Neuropsychopharmacology · Springer Nature (8)
- Apoptosis · Springer Nature (0)
- BMC Pharmacology and Toxicology · Springer Nature (0)
- BioDrugs · Springer Nature (0)
- Cardiovascular Drugs and Therapy · Springer Nature (0)
- Current Cardiovascular Risk Reports · Springer Nature (0)
- Current Pharmacology Reports · Springer Nature (0)
- DARU Journal of Pharmaceutical Sciences · Springer Nature (0)
- Drug Safety · Springer Nature (0)
- European Journal of Clinical Pharmacology · Springer Nature (0)
- European Journal of Drug Metabolism and Pharmacokinetics · Springer Nature (0)
- Future Journal of Pharmaceutical Sciences · Springer Nature (0)
- Inflammation Research · Springer Nature (0)
- Journal of Pharmacokinetics and Pharmacodynamics · Springer Nature (0)
- Naunyn-Schmiedeberg's Archives of Pharmacology · Springer Nature (0)
- Pharmaceutical Research · Springer Nature (0)
- PharmacoEconomics - Open · Springer Nature (0)
- Pharmacological Reports · Springer Nature (0)
- Psychopharmacology · Springer Nature (0)
- Saudi Pharmaceutical Journal · Springer Nature (0)
- Associations between kratom (Mitragyna Speciosa) use and real-time anxiety and sadness: A 15-day ecological momentary assessment study
- Nationwide trends of six medications for alcohol use disorder prescriptions post-discharge in patients hospitalized with alcohol-associated liver disease between 2015 and 2024
- Absorption, distribution, metabolism and excretion of sepiapterin, a natural precursor of tetrahydrobiopterin
- PKA-dependent phosphorylation of PSMG1 reduces bortezomib sensitivity in hepatocellular carcinoma
- Physiologically Based Pharmacokinetic Model Incorporating Enterohepatic Circulation of Multi-kinase Inhibitor Regorafenib to Explain Prolonged Exposure After Single and Repeated Dosing
- Investigation of the Nonlinear Pharmacokinetics of Vismodegib in Humans: Using PBPK Modeling to Examine Contributions of Saturable Plasma Protein Binding and Nonsink Permeation
- Calibrating public genome archives for AMR surveillance: Four decades of redundancy-aware phylogenomics of pandemic Escherichia coli ST131
- Single-cell and spatial analysis of inflammation-associated resistance in intrahepatic cholangiocarcinoma
- ER stress-induced chaperone-assisted selective autophagy confers resistance to mitotic catastrophe-driven anticancer effects by degrading toxic protein aggregates to inhibit caspase-2 activation
- CARM1 orchestrates hypoxia-mediated chemoresistance through the H3R17me2a/FUS upregulation in colorectal cancer
- One Health genomic surveillance reveals transmission networks, resistance profiles and dissemination patterns of carbapenem-resistant Acinetobacter baumannii
- A Th17-centered immune network for tertiary lymphoid structure formation in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy
- Absorption, distribution, metabolism, and excretion of the BMS-986365 ligand-directed degrader diastereomers, R,R-[14C]BMS-986409 and R,S-[14C]BMS-986410, following oral administration in combination with an intravenous microtracer in healthy male participants
- County-level context and differential policy impacts on buprenorphine use among medicaid enrollees with opioid use disorder in Kentucky, 2018–2025
- Incidence of opioid use disorder among patients prescribed long-term opioid therapy: An observational study
- Sociodemographic and intersecting sociodemographic subgroups in relation to US adult tobacco use trajectories over a 10-year period: Analysis of Population Assessment of Tobacco and Health (PATH) data
- Systematic search on fat free mass and fat mass in exclusively breastfed infants until one year of age – a contribution from the ConcePTION project
- Real-world use of digital therapeutics for substance use disorders in primary care: Observational study of the engagement cascade by substance type
- Medication for opioid use disorder following urine drug testing: An observational cohort study of linked national laboratory and medical and pharmacy claims data
- AKR1B1-dependent ferroptosis defense contributes to KRASG12C inhibitor resistance in pancreatic ductal adenocarcinoma
- Extracellular vesicle-mediated drug resistance in cancer
- Structural insights into P-glycoprotein substrate polyspecificity: A dynamic conformational sampling model
- Age and intensive care unit admissions following opioid overdose
- Quantitative determination of lysosomal accumulation fraction, flyso, for estimating Kp,uu,brain tumor and target coverage for drugs treating human glioblastoma
- Opioid misuse and opioid use disorder by sexual identity in U.S. adults: Findings from the 2021–2022 NSDUH
- Longitudinal pathways from prenatal alcohol exposure and infant behaviors to adult verbal IQ and working memory
- Advancements in peptidomimetics as a strategy against multidrug resistance: Fundamentals, rational design, resistance mechanisms, and artificial intelligence
- Neural programs of therapy resistance in cancer: A mechanism-first framework for therapeutic targeting
- Drug resistance mechanisms and sensitization strategies in central nervous system tumors
- Macrophage-centered resistance programs in cancer: A unified framework for therapeutic resistance and precision immunotherapy